These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4874512)

  • 1. [Complications following dietary faults during treatment with MAO inhibitors].
    Langwiński R
    Psychiatr Pol; 1967; 1(3):337-42. PubMed ID: 4874512
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monoamine oxidase inhibitors and pressor response to dietary amines].
    Tipton KF
    Vopr Med Khim; 1997; 43(6):494-503. PubMed ID: 9503566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAOIs and dietary restrictions.
    Rogers GA
    J Clin Psychiatry; 1982 Nov; 43(11):472. PubMed ID: 7174628
    [No Abstract]   [Full Text] [Related]  

  • 4. Cheese effects and new reversible MAO A inhibitors: summary.
    Rafaelsen OJ
    J Neural Transm Suppl; 1988; 26():123-4. PubMed ID: 3162951
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary consideration in MAO inhibitor regimens.
    McCabe B; Tsuang MT
    J Clin Psychiatry; 1982 May; 43(5):178-81. PubMed ID: 7076627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarifying the safety of the MAOI diet and pizza.
    Feinberg S; Holzer B
    J Clin Psychiatry; 2000 Feb; 61(2):145-6. PubMed ID: 10732665
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient compliance with MAO inhibitor therapy.
    Walker JI; Davidson J; Zung WW
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):78-80. PubMed ID: 6735998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
    Bieck PR; Antonin KH; Schmidt E
    Clin Neuropharmacol; 1993; 16 Suppl 2():S34-41. PubMed ID: 8313395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of MAO inhibitors: safety and future.
    Yamada M; Yasuhara H
    Neurotoxicology; 2004 Jan; 25(1-2):215-21. PubMed ID: 14697896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the bottom line for dietary guidelines when taking monoamine oxidase inhibitors?
    Marcason W
    J Am Diet Assoc; 2005 Jan; 105(1):163. PubMed ID: 15635366
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K
    Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art.
    Rapaport MH
    J Clin Psychiatry; 2007; 68 Suppl 8():42-6. PubMed ID: 17640157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors.
    Bainbridge JL; Page RL; Ruscin JM
    Neurol Clin; 2008 Aug; 26(3 Suppl):S85-96, vi. PubMed ID: 18774444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions with reversible monoamine oxidase-A inhibitors.
    Callingham BA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S42-50. PubMed ID: 8313396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical contribution to the knowledge of the so-called "cheese syndrome"].
    Boccaletti E; Naso O; Micchia MT
    Policlinico Prat; 1965 Nov; 72(46):1562-5. PubMed ID: 5879813
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute hypertension after monoamine-oxidase inhibitors and the ingestion of cheese.
    Muscholl E
    Ger Med Mon; 1965 Aug; 10(8):337-8. PubMed ID: 5828962
    [No Abstract]   [Full Text] [Related]  

  • 18. Aged cheese, pargyline hydrochloride, and paradoxical hypertension.
    Carmichael DB
    J Lancet; 1966 May; 86(5):235-8. PubMed ID: 5910166
    [No Abstract]   [Full Text] [Related]  

  • 19. Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction.
    van Amsterdam J; Talhout R; Vleeming W; Opperhuizen A
    Life Sci; 2006 Oct; 79(21):1969-73. PubMed ID: 16884739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.